Viewing data from:

NAPROXEN SODIUM

ANDA

NAPROXEN SODIUM | A204872 | LNK INTERNATIONAL INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 6 NDCs

Highest NADAC/Unit

$0.0663

per ea

Lowest NADAC/Unit

$0.0663

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
46122056258GNP NAPROXEN SOD 220 MG TABLET	$0.0663	EA	Generic	—	2026-06-17
46122056271GNP NAPROXEN SOD 220 MG TABLET	$0.0663	EA	Generic	—	2026-06-17
46122056278NAPROXEN SODIUM 220 MG TABLET	$0.0663	EA	Generic	—	2026-06-17
46122056471GNP NAPROXEN SOD 220 MG CAPLET	$0.0663	EA	Generic	—	2026-06-17
46122056478GNP NAPROXEN SOD 220 MG CAPLET	$0.0663	EA	Generic	—	2026-06-17
46122056481GNP NAPROXEN SOD 220 MG CAPLET	$0.0663	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 1 NDC (1 FSS)

Lowest Price

$2.99

Highest Price

$2.99

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
57896-0954-01NAPROXEN NA 220MG TAB	$2.99	FSS	Geri-Care Pharmaceutical Corp	06/14/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain9 active DMFs14 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

DR REDDYS LABORATORIES LTDNAPROXEN SODIUM

DMF 32081978

TAPI NL BVNAPROXEN SODIUM

DMF 87461990

DR REDDYS LABORATORIES LTDNAPROXEN SODIUM

DMF 123421997

ZHEJIANG CHARIOTEER PHARMACEUTICAL CO LTDNAPROXEN SODIUM, USP (BULK)

DMF 132431998

DIVIS LABORATORIES LTDNAPROXEN SODIUM USP

DMF 138671998

APITORIA PHARMA PRIVATE LTDNAPROXEN SODIUM USP NON STERILE DRUG SUBSTANCE

DMF 228322009

ZHEJIANG CHARIOTEER PHARMACEUTICAL CO LTDNAPROXEN SODIUM GRANULE

DMF 264022012

SOLARA ACTIVE PHARMA SCIENCES LTDNAPROXEN SODIUM USP

DMF 375262022

HETERO LABS LTDNAPROXEN SODIUM

DMF 382162023

DINAMITE DIPHARMA SPAInactiveNAPROXEN SODIUM

DMF 54781984

CAMBREX PROFARMACO MILANO SRLInactiveNAPROXEN SODIUM

DMF 67121986

NOBEL CHEMICALS AB DIV FINE CHEMICALS INCInactiveNAPROXEN SODIUM USP

DMF 71311987

ZAMBON SPAInactiveNAPROXEN SODIUM

DMF 74561988

RALLIS INDIA LTDInactiveNAPROXEN SODIUM

DMF 75691988

ALFA WASSERMANN SPAInactiveNAPROXEN SODIUM

DMF 84361990

FARCHEMIA SRLInactiveNAPROXEN SODIUM USP

DMF 116271996

ALBEMARLE CORPInactiveNAPROXEN SODIUM

DMF 119401996

VERA LABORATORIES LTDInactiveNAPROXEN SODIUM

DMF 125591997

NATCO PHARMA LTDInactiveNAPROXEN SODIUM, USP

DMF 128921998

SOLARA ACTIVE PHARMA SCIENCES LTDInactiveNAPROXEN SODIUM USP

DMF 141851999

MYLAN LABORATORIES LTDInactiveNAPROXEN SODIUM USP

DMF 157322001

VERA LABORATORIES LTDInactiveNAPROXEN SODIUM

DMF 162002002

GRANULES INDIA LTDInactiveNAPROXEN SODIUM, USP

DMF 346912020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jan 27, 2017	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 220MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jan 23, 2017

No patent or exclusivity listings for this strength.